Basic Information | Post buying leads | Suppliers |
Name |
3,5,3'-Triiodo-4'-acetylthyroformic acid |
EINECS | N/A |
CAS No. | 1160-36-7 | Density | 2.345g/cm3 |
PSA | 63.60000 | LogP | 5.19350 |
Solubility | N/A | Melting Point |
N/A |
Formula | C15H9 I3 O4 | Boiling Point | 571.8°Cat760mmHg |
Molecular Weight | 633.94 | Flash Point | 299.6°C |
Transport Information | N/A | Appearance | N/A |
Safety | Moderately toxic by ingestion, intraperitoneal, and subcutaneous routes. Experimental reproductive effects. When heated to decomposition it emits toxic fumes of I−. | Risk Codes | N/A |
Molecular Structure | Hazard Symbols | N/A | |
Synonyms |
TBF 43 |
IUPAC Name: 4-(4-Acetyl-3-iodophenoxy)-3,5-diiodobenzoic acid
Synonyms: 3,5,3'-Triiodo-4'-acetylthyroformic acid ; 3,5-Diiodo-4-(3'-iodo-4'-acetoxyphenoxy)benzoic acid ; Benzoic acid, 4-(4-acetyl-3-iodophenoxy)-3,5-diiodo-
CAS NO: 1160-36-7
Molecular Formula of 3,5,3'-Triiodo-4'-acetylthyroformic acid (CAS NO.1160-36-7) :C15H9I3O4
Molecular Weight of 3,5,3'-Triiodo-4'-acetylthyroformic acid (CAS NO.1160-36-7) : 633.943
Molecular Structure of 3,5,3'-Triiodo-4'-acetylthyroformic acid (CAS NO.1160-36-7) :
Index of Refraction:1.734
Surface Tension: 66.7 dyne/cm
Density: 2.345 g/cm3
Flash Point: 299.6 °C
Enthalpy of Vaporization: 90.18 kJ/mol
Boiling Point: 571.8 °C at 760 mmHg
Vapour Pressure: 6.52E-14 mmHg at 25°C
Organism | Test Type | Route | Reported Dose (Normalized Dose) | Effect | Source |
---|---|---|---|---|---|
mouse | LD50 | intraperitoneal | 1gm/kg (1000mg/kg) | BEHAVIORAL: SOMNOLENCE (GENERAL DEPRESSED ACTIVITY) LUNGS, THORAX, OR RESPIRATION: DYSPNEA GASTROINTESTINAL: "HYPERMOTILITY, DIARRHEA" | Takeda Kenkyusho Ho. Journal of the Takeda Research Laboratories. Vol. 29, Pg. 207, 1970. |
mouse | LD50 | oral | 3700mg/kg (3700mg/kg) | BEHAVIORAL: SOMNOLENCE (GENERAL DEPRESSED ACTIVITY) LUNGS, THORAX, OR RESPIRATION: DYSPNEA GASTROINTESTINAL: "HYPERMOTILITY, DIARRHEA" | Takeda Kenkyusho Ho. Journal of the Takeda Research Laboratories. Vol. 29, Pg. 207, 1970. |
mouse | LD50 | subcutaneous | 2300mg/kg (2300mg/kg) | BEHAVIORAL: SOMNOLENCE (GENERAL DEPRESSED ACTIVITY) LUNGS, THORAX, OR RESPIRATION: DYSPNEA GASTROINTESTINAL: "HYPERMOTILITY, DIARRHEA" | Takeda Kenkyusho Ho. Journal of the Takeda Research Laboratories. Vol. 29, Pg. 207, 1970. |
rat | LD50 | intraperitoneal | 480mg/kg (480mg/kg) | BEHAVIORAL: MUSCLE WEAKNESS GASTROINTESTINAL: "HYPERMOTILITY, DIARRHEA" | Takeda Kenkyusho Ho. Journal of the Takeda Research Laboratories. Vol. 29, Pg. 207, 1970. |
rat | LD50 | oral | 4600mg/kg (4600mg/kg) | BEHAVIORAL: MUSCLE WEAKNESS GASTROINTESTINAL: "HYPERMOTILITY, DIARRHEA" | Takeda Kenkyusho Ho. Journal of the Takeda Research Laboratories. Vol. 29, Pg. 207, 1970. |
rat | LD50 | subcutaneous | 520mg/kg (520mg/kg) | BEHAVIORAL: MUSCLE WEAKNESS GASTROINTESTINAL: "HYPERMOTILITY, DIARRHEA" | Takeda Kenkyusho Ho. Journal of the Takeda Research Laboratories. Vol. 29, Pg. 207, 1970. |
Moderately toxic by ingestion, intraperitoneal, and subcutaneous routes. Experimental reproductive effects. When heated to decomposition it emits toxic fumes of I−.